Related News
August
25,
2026
Henry Ford Health researcher Alyssa Vanderziel, Ph.D., has received a nearly $1 million NIH grant to develop and test a patient-centered digital intervention aimed at reducing cannabis use during pregnancy and improving health outcomes for mothers and infants in Michigan.
August
24,
2026
Unique Henry Ford Health program blends gardening, cooking and feeding therapy to support families raising children with autism and food-related challenges
August
10,
2026
New campaign shows how science, discovery and compassionate care come together to improve lives.
August
10,
2026
Same-Day Solutions Model helps patients access behavioral health care services sooner, streamlines referral processes
July
30,
2026
LightHearted AI and M3D are the first companies to receive investment from the healthcare-focused venture fund backed by Henry Ford Health, Michigan State University, and the MSU Research Foundation.
July
27,
2026
Experienced health care leader returns to Henry Ford Health to lead hospital operations, strategy and continued growth in Rochester.
July
17,
2026
Henry Ford Health selected as one of only four U.S. academic health systems in Bayer’s strategic research network
July
16,
2026
Construction work is part of Destination: Grand campus expansion project transforming Henry Ford Hospital in Detroit.
July
14,
2026
Patients at Henry Ford Health have access to the Sonata System, a minimally invasive incisionless alternative for managing fibroids and their symptoms.
July
13,
2026
New service will help safely move seriously ill babies and children to specialized pediatric care at Henry Ford St. John Children’s Hospital.
Media Briefing on Moderna Vaccine Trial
November
16,
2020

Henry Ford Health System discussed its role in the Moderna vaccine trial after the drugmaker announced today that early data from its mRNA trial showed its vaccine is 94.5% effective. Henry Ford was the only hospital in Michigan and one of about 90 nationally chosen to participate in the trial. Henry Ford was a key site for enrolling minority volunteers who were hardest hit by COVID-19.
Leading the media briefing are Paul Kilgore, M.D., MPH, a Henry Ford co-principal investigator in the vaccine trial, and Kellie McFarlin, M.D., a Henry Ford general surgeon and a volunteer vaccine participant. They were joined by Melanie Ivarsson, Ph.D., chief development officer for Moderna.